Hydrocephalus treatment

Details Hydrocephalus treatment Hydrocephalus treatment

2004-11-19

2009-11-17

Ulm, John D (Department: 1649)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

C435S069100, C435S069400, C530S399000

Reexamination Certificate

active

07618614

ABSTRACT:
A method and compound for treatment of hydrocephalus is presented. Hepatocyte growth factor (HGF) is administered intraventricularly.

REFERENCES:
patent: 5840311 (1998-11-01), Nakamura et al.
patent: 2002/0013265 (2002-01-01), Schwartz
patent: A 7-300426 (1995-11-01), None
Tsuzuki et al., Neurological Research, 23(4): 417-424, Jun. 2001.
Tsuzuki et al. Acta Neurochirurgica Supplement, 76:311-316, 2000.
Fukumizu et al., Pediatric Neurology, 13(3):230-234, published Oct. 1995.
Y. Tsuboi et al., “Hepatocyte Growth Factor in Cerebrospinal Fluid in Neurologic Disease”, ACTA Neurologica Scandinavica, vol. 106, pp. 99-103, 2002.
Tsuyoshi Tada et al., “Intraventricular Administration of Hepatocyte Growth Factor Treats Mouse Communicating Hydrocephalus Induced by Transforming Growth Fact β1”, Neurobiology of Disease, vol. 21, pp. 576-586, 2006.
Di Rocco et al., “Anatomo-Clinical Correlations in Normotensive Hydrocephalus,” Journal of the Neurological Sciences, vol. 33, pp. 437-452, 1977.
Yasargil et al., “Hydrocephalus following spontaneous subarachnoid hemorrhage, Clinical features and treatment,” J. Neurosurg., vol. 39, pp. 474-479, Oct. 1973.
Almuneef et al., “Childhood Bacterial Meningitis in Saudi Arabia,” Journal of Infection, vol. 36, pp. 157-160, 1998.
Daoud et al., “Indications and Benefits of Computed Tomography in Childhood Bacterial Meningitis,” Journal of Tropical Pediatrics, vol. 44, pp. 167-169, Jun. 1998.
Gomes et al., “Prognosis of Bacterial Meningitis in Children,” Arq Neuropsiquiatr, vol. 54, No. 3, pp. 407-411, 1996.
Grimwood et al., “Adverse Outcomes of Bacterial Meningitis in School-Age Survivors,” Pediatrics, vol. 95, No. 5, pp. 646-656, May 1995.
Youmans, J.R., Chapter 36; “Hydrocephalus in Childhood,” Neurological Surgery, Fourth Edition, vol. 2, W.B. Saunders Company, Philadelphia, pp. 890-926, 1996.
Graff-Radford et al., “Factors Associated With Hydrocephalus After Subarachnoid Hemorrhage, A Report of the Cooperative Aneurysm Study,” Arch Neurol, vol. 46, pp. 744-752, Jul. 1989.
Pfister et al., “Spectrum of Complications During Bacterial Meningitis in Adults, Results of a Prospective Clinical Study,” Arch. Neurol, vol. 50, No. 6, pp. 575-581, Jun. 1993.
Lobato et al., Hydrocephalus in cerebral cysticercosis, Pathogenic and therapeutic considerations, J. Neurosurg., vol. 55, pp. 786-793, Nov. 1981.
Torvik et al., “Transitory Block of the Arachnoid Granulations Following Subarachnoid Haemorrhage: A Postmortem Study,” Acta Neurochirurgica,vol. 41, pp. 137-146, 1978.
Akai et al., “Normal Pressure Hydrocephalus, Neuropathological Study,” Acta Pathol. Jpn., vol. 37, No. 1, pp. 97-110, 1987.
Massicotte et al., “Human arachnoid villi response to subarachnoid hemorrhage: possible relationship to chronic hydrocephalus,” J. Neurosurg., vol. 91, pp. 80-84, Jul. 1999.
Motohashi et al., Subarachnoid Haemorrhage Induced Proliferation of Leptomeningeal Cells and Deposition of Extracellular Matrices in the Arachnoid Granulations and Subarachnoid Space, Acta Neurochir, vol. 136, pp. 88-91, 1995.
Kang et al., “Long-term follow-up of shunting therapy,” Child's Nerv Syst, vol. 15, pp. 711-717, 1999.
Sgouros et al., “Long-Term Complications of Hydrocephalus,” Pediatr Neurosurg, vol. 23, pp. 127-132, 1995.
Del Bigio, “Epidemiology and Direct Economic Impact of Hydrocephalus: A Community Based Study,” Can J. Neurol. Sci., vol. 25, pp. 123-126, 1998.
Nakamura et al., “Molecular cloning and expression of human hepatocyte growth factor,” Nature, vol. 342, pp. 440-443, Nov. 23, 1989.
Miyazawa et al., “Molecular Cloning and Sequence Analysis of the cDNA for a Human Serine Protease Responsible for Activation of Hepatocyte Growth Factor,” The Journal of Biological Chemistry, vol. 268, No. 14, pp. 10024-10028, 1993.
Dohi et al., “Hepatocyte Growth Factor Attenuates Collagen Accumulation in a Murine Model of Pulmonary Fibrosis,” Am J Respir Crit Care Med, vol. 162, pp. 2302-2307, 2000.
Matsuda et al., “Hepatocyte Growth Factor Suppresses the Onset of Liver Cirrhosis and Abrogates Lethal Hepatic Dysfunction in Rats,” J. Biochem, vol. 118, No. 3, pp. 643-649, 1995.
Fujimoto, “Hepatology: Microcirculation and Pathogenesis of Alcoholic Liver Injury, Gene therapy for liver cirrhosis,” Journal of Gastroenterology and Hepatology, vol. 15 (Suppl.), pp. D33-D36, 2000.
Vargas et al., “Hepatocyte growth factor in renal failure: Promise and reality,” Kidney International, vol. 57, pp. 1426-1436, 2000.
Rosen et al., “Scatter Factor and thec-MetReceptor: A Paradigm for Mesenchymal/Epithelial Interaction,” The Journal of Cell Biology, vol. 127, No. 6, Part 2, pp. 1783-1787, Dec. 1994.
Brinkmann et al., “Hepatocyte Growth Factor/Scatter Factor Induces a Variety of Tissue-Specific Morphogenic Programs In Epithelial Cells,” The Journal of Cell Biology, vol. 131, No. 6, Part 1, pp. 1573-1586, Dec. 1995.
Ohmichi et al., “Hepatocyte growth factor (HGF) acts as a mesenchyme-derived morphogenic factor during fetal lung development,” Development, vol. 125, pp. 1315-1324, 1998.
Matsumoto et al., “Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics,” Current Opinion in Nephrololgy and Hypertension, vol. 9, pp. 395-402, 2000.
Flood et al., “Transforming Growth Factor-β1 in the Cerebrospinal Fluid of Patients with Subarachnoid Hemorrhage: Titers Derived From Exogenous and Endogenous Sources,” Journal of Cerebral Blood Flow and Metabolism, vol. 21, pp. 157-162, 2001.
Takizawa et al., “Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage,” Neurological Research, vol. 23, pp. 724-730, Oct. 2001.
Ossege et al., “Expression of tumor necrosis factor-α and transforming growth factor-β1 in cerebrospinal fluid cells in meningitis,” Journal of the Neurological Sciences, vol. 144, pp. 1-13, 1996.
Hunag et al., “Level of transforming growth factor beta 1 is elevated in cerebrospinal fluid of children with acute bacterial meningitis,” J. Neurol, vol. 244, pp. 634-638, 1997.
Galbreath et al., “Overexpression of TGF-β1 in the Central Nervous System of Transgenic Mice Results in Hydrocephalus,” Journal of Neuropathology and Experimental Neurology, vol. 54, No. 3, pp. 339-349, May 1995.
Wyss-Coray et al., “Increased Central Nervous System Production of Extracellular Matrix Components and Development of Hydrocephalus in Transgenic Mice Overexpressing Transforming Growth Factor-β1,” American Journal of Pathology, vol. 147, No. 1, pp. 53-67, Jul. 1995.
Cohen et al., “Characterization of a model of hydrocephalus in transgenic mice,” J. Neurosurg., vol. 91, pp. 978-988, Dec. 1999.
Stoddart, Jr. et al., “Transgenic Mice with a Mutated Collagen Promoter Display Normal Response During Bleomycin-Induced Fibrosis and Possess Neurological Abnormalities,” Journal of Cellular Biochemistry, vol. 77, pp. 135-148, 2000.
Hayashi et al., “Chronological Changes of Cerebral Ventricular Size in a Transgenic Model of Hydrocephalus,” Pediatric Neurosurgery, vol. 33, No. 4, pp. 182-187, 2000.
Morris, “Spatial Localization Does Not Require the Presence of Local Cues,” Learning and Motivation, vol. 12, pp. 239-260, 1981.
Sarnyai et al., “Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin1Areceptors,” PNAS, vol. 97, No. 26, pp. 14731-14736, Dec. 19, 2000.
Cruz et al., “Observations on the use of medetomidine/ketamine and its reversal with atipamezole for chemical restraint in the mouse,” Laboratory Animals, vol. 32, No. 1, pp. 18-22, Jun. 9

Affiliated with

Also associated with

Rating

Hydrocephalus treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydrocephalus treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrocephalus treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4131137